Long form of latent TGF‐β binding protein 1 (Ltbp1L) regulates cardiac valve development

Transforming Growth Factor β (TGF‐β) is crucial for valve development and homeostasis. The long form of Latent TGF‐β binding protein 1 (LTBP1L) covalently binds all TGF‐β isoforms and regulates their bioavailability. Ltbp1L expression analysis during valvulogenesis revealed two patterns of Ltbp1L production: an early one (E9.5–11.5) associated with endothelial‐to‐mesenchymal transformation (EMT); and a late one (E12.5 to birth) contemporaneous with valve remodeling. Similarly, histological analysis of Ltbp1L−/− developing valves identified two different pathologies: generation of hypoplastic endocardial cushions in early valvulogenesis, followed by development of hyperplastic valves in late valvulogenesis. Ltbp1L promotes valve EMT, as Ltbp1L absence yields hypoplastic endocardial cushions in vivo and attenuated EMT in vitro. Ltbp1L−/− valve hyperplasia in late valvuogenesis represents a consequence of prolonged EMT. We demonstrate that Ltbp1L is a major regulator of Tgf‐β activity during valvulogenesis since its absence results in a perturbed Tgf‐β pathway that causes all Ltbp1L−/− valvular defects. Developmental Dynamics, 2011. © 2010 Wiley‐Liss, Inc.

[1]  Kuniya Abe,et al.  Outflow tract cushions perform a critical valve-like function in the early embryonic heart requiring BMPRIA-mediated signaling in cardiac neural crest. , 2009, American journal of physiology. Heart and circulatory physiology.

[2]  R. Hynes.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[3]  P. Howe,et al.  The tale of transforming growth factor‐beta (TGFβ) signaling: A soigné enigma , 2009, IUBMB life.

[4]  D. Rifkin,et al.  Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. , 2009, Current opinion in cell biology.

[5]  K. Yutzey,et al.  Heart Valve Development: Regulatory Networks in Development and Disease , 2009, Circulation research.

[6]  H. von Melchner,et al.  Dual functions for LTBP in lung development: LTBP‐4 independently modulates elastogenesis and TGF‐β activity , 2009, Journal of cellular physiology.

[7]  Raymond B. Runyan,et al.  Ligand‐specific function of transforming growth factor beta in epithelial‐mesenchymal transition in heart development , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[8]  Kohei Miyazono,et al.  Snail is required for TGFβ-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells , 2008, Journal of Cell Science.

[9]  R. Schwartz,et al.  Signaling via the Tgf-beta type I receptor Alk5 in heart development. , 2008, Developmental biology.

[10]  J. Bischoff,et al.  Opposing actions of Notch1 and VEGF in post-natal cardiac valve endothelial cells. , 2008, Biochemical and biophysical research communications.

[11]  R. Markwald,et al.  Periostin regulates atrioventricular valve maturation. , 2008, Developmental biology.

[12]  R. Markwald,et al.  Periostin Is Required for Maturation and Extracellular Matrix Stabilization of Noncardiomyocyte Lineages of the Heart , 2008, Circulation research.

[13]  A. Murphy,et al.  Long form of latent TGF-β binding protein 1 (Ltbp1L) is essential for cardiac outflow tract septation and remodeling , 2007 .

[14]  D. Srivastava,et al.  Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. , 2007, Circulation.

[15]  Raymond B. Runyan,et al.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. , 2007, Developmental biology.

[16]  D. Judge,et al.  Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic states , 2007, Nature Medicine.

[17]  H. Moses,et al.  Tgfβ signaling is required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development , 2006, Development.

[18]  S. Oparil,et al.  Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. , 2006, Atherosclerosis.

[19]  R. Hinton,et al.  Extracellular Matrix Remodeling and Organization in Developing and Diseased Aortic Valves , 2006, Circulation research.

[20]  D. Judge,et al.  Therapy for Marfan Syndrome , 2006, Science.

[21]  A. Majithia,et al.  The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling , 2006, Development.

[22]  R. Schwartz,et al.  Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning , 2005, Development.

[23]  J. Epstein,et al.  Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. , 2005, Developmental biology.

[24]  D. Rifkin.  Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability* , 2005, Journal of Biological Chemistry.

[25]  D. Judge,et al.  TGF-β–dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome , 2004 .

[26]  Robert H. Anderson,et al.  Lineage and Morphogenetic Analysis of the Cardiac Valves , 2004, Circulation research.

[27]  Joyce Bischoff,et al.  Heart valve development: endothelial cell signaling and differentiation. , 2004, Circulation research.

[28]  A. Roberts,et al.  Smad3 Null Mice Develop Airspace Enlargement and Are Resistant to TGF-β-Mediated Pulmonary Fibrosis1 , 2004, The Journal of Immunology.

[29]  Katherine E Yutzey,et al.  Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[30]  R. Markwald,et al.  Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. , 2004, Developmental biology.

[31]  P. Dijke,et al.  New insights into TGF-β–Smad signalling , 2004 .

[32]  Jonas Larsson,et al.  Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.

[33]  G. Dorn,et al.  Transforming growth factor beta in cardiovascular development and function. , 2003, Cytokine & growth factor reviews.

[34]  David C. Lee,et al.  Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling , 2003, Journal of Molecular Medicine.

[35]  A. Gressner,et al.  The murine latent transforming growth factor-beta binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21-22. , 2003, Gene.

[36]  D. Arking,et al.  Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome , 2003, Nature Genetics.

[37]  Justin P. Annes,et al.  Making sense of latent TGFβ activation , 2003, Journal of Cell Science.

[38]  J. Otte,et al.  Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer. , 2002, Genes & development.

[39]  Raymond B. Runyan,et al.  Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. , 2002, Developmental biology.

[40]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[41]  D. Rifkin,et al.  Bone abnormalities in latent TGF-β binding protein (Ltbp)-3–null mice indicate a role for Ltbp-3 in modulating TGF-β bioavailability , 2002, The Journal of cell biology.

[42]  T. Doetschman,et al.  Double-Outlet Right Ventricle and Overriding Tricuspid Valve Reflect Disturbances of Looping, Myocardialization, Endocardial Cushion Differentiation, and Apoptosis in TGF-β2–Knockout Mice , 2001 .

[43]  S. Klewer,et al.  Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. , 2000, The Journal of clinical investigation.

[44]  M. Shaw,et al.  Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation. , 2000, Developmental biology.

[45]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[47]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[48]  J. Keski‐Oja,et al.  Independent Promoters Regulate the Expression of Two Amino Terminally Distinct Forms of Latent Transforming Growth Factor-β Binding Protein-1 (LTBP-1) in a Cell Type-specific Manner* , 1999, The Journal of Biological Chemistry.

[49]  Lynda F. Bonewald,et al.  Identification and Characterization of a Novel Protein, Periostin, with Restricted Expression to Periosteum and Periodontal Ligament and Increased Expression by Transforming Growth Factor β , 1999 .

[50]  D. L. Weeks,et al.  TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. , 1999, Developmental biology.

[51]  R. Markwald,et al.  The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. , 1998, Developmental biology.

[52]  K. Miyazono,et al.  Extracellular Fibrillar Structure of Latent TGFβ Binding Protein-1: Role in TGFβ-dependent Endothelial-Mesenchymal Transformation during Endocardial Cushion Tissue Formation in Mouse Embryonic Heart , 1997, The Journal of cell biology.

[53]  Raymond B. Runyan,et al.  Antibodies to the Type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. , 1996, Developmental biology.

[54]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[55]  Raymond B. Runyan,et al.  Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta. , 1989, Developmental biology.

[56]  D. Rifkin,et al.  Latent TGF-beta binding proteins. , 2005, The international journal of biochemistry & cell biology.

[57]  D. Rifkin.  Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. , 2005, The Journal of biological chemistry.

[58]  Raymond B. Runyan,et al.  Cell biology of cardiac cushion development. , 2005, International review of cytology.

[59]  D. Rifkin,et al.  Latent TGF-β binding proteins , 2005 .

[60]  J. Borer,et al.  The epidemiology of valvular heart diseases: the problem is growing. , 2004, Advances in cardiology.

[61]  D. Judge,et al.  TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. , 2004, The Journal of clinical investigation.

[62]  C. Hill,et al.  New insights into TGF-beta-Smad signalling. , 2004, Trends in biochemical sciences.

[63]  D. Rifkin,et al.  Making sense of latent TGFbeta activation. , 2003, Journal of cell science.

[64]  D. Arking,et al.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. , 2003, Nature genetics.

[65]  K. Horiuchi,et al.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.